GLYCOPYRRONIUM,INDACATEROL,MOMETASONE
Background and Date of Approval
Glycopyrronium, indacaterol, and mometasone combination is an inhaled medication approved for the management of chronic obstructive pulmonary disease (COPD) and asthma. This fixed-dose combination delivers triple therapy, providing bronchodilation and anti-inflammatory effects. Glycopyrronium is an anticholinergic; indacaterol is a long-acting β2-agonist (LABA); and mometasone is a corticosteroid. These three agents work together to relieve airway obstruction and inflammation. The combination received approval from the European Medicines Agency (EMA) in 2020 and has been evaluated in clinical trials that have shown efficacy in reducing exacerbations and improving lung function.
Uses
FDA-approved uses of this combination include: Management of Chronic Obstructive Pulmonary Disease (COPD) Treatment of Asthma (in patients where monotherapy is insufficient) Reducing exacerbation rates in patients with COPD or asthma
How is it administered?
The combination is administered via inhalation using a dry powder inhaler or pressurised metered-dose inhaler. The standard dosage is usually one inhalation daily, but specific doses may vary based on the severity of the condition and patient response. It is essential to follow the prescribing healthcare provider's instructions for optimal results.
Side Effects
Serious Side Effects Irregular heartbeats Severe allergic reactions (rash, itching, swelling) Chest pain or discomfort Vision changes (e.g., blurred vision, eye pain) Difficulty urinating Common Side Effects Dry mouth Cough Headache Sore throat Nausea Hoarseness
Warnings
Not suitable for individuals with severe hypersensitivity to any of the active ingredients. May interact adversely with other bronchodilators or corticosteroids. Increased risk of cardiovascular complications in patients with underlying heart conditions. Avoid use during acute asthma or COPD exacerbations requiring emergency intervention. Should not be used as the primary treatment for asthma relief.
Precautions
Before using this combination therapy, patients should inform their healthcare provider of their complete medical history, especially if they have heart disease, hypertension, glaucoma, urinary retention, or osteoporosis. Regular monitoring of lung function and bone density is advisable during prolonged use. Patients should be cautious about potential side effects and consult their physician if symptoms worsen or new symptoms emerge.
Word of Advice
This combination therapy delivers optimal benefit when used regularly according to prescription. It is not indicated for relief of acute symptoms, and patients should maintain a rescue inhaler available for emergency use. Rinsing the mouth following inhalation helps prevent oral thrush. Store the inhaler in a cool, dry location and protect from extreme temperature exposure.
References
https://pubmed.ncbi.nlm.nih.gov/33871819/ https://www.ncbi.nlm.nih.gov/books/NBK568878/ https://www.sciencedirect.com/science/article/pii/S1094553920301681 https://adisinsight.springer.com/drugs/800042720
Frequently Asked Questions
What is Glycopyrronium, Indacaterol, and Mometasone used for?
Glycopyrronium, Indacaterol, and Mometasone combination is primarily prescribed for managing chronic obstructive pulmonary disease (COPD) and asthma. It works by improving lung function, reducing inflammation, and preventing exacerbations. By combining a bronchodilator, an anticholinergic, and a corticosteroid, it provides comprehensive respiratory relief. Regular use helps maintain symptom control and enhances the quality of life.
What is the best time to take Glycopyrronium, Indacaterol, and Mometasone combination?
It is recommended to take this medication once daily, preferably at the same time each day. Maintaining consistency in timing ensures optimal efficacy and helps establish a routine. Morning administration is often preferred, but it can be taken at any convenient time. Always adhere to the healthcare providerâs guidance for best results.
Should the Glycopyrronium, Indacaterol, and Mometasone combination be taken before or after meals?
This medication can be taken regardless of meals. Food intake does not affect its absorption or efficacy since it is administered via inhalation. However, it is essential to follow your healthcare providerâs instructions regarding dosage and timing. Always ensure proper inhalation technique for maximum benefit.
Can a Glycopyrronium, Indacaterol, and Mometasone combination be used for acute asthma attacks?
No, this combination is not intended for acute asthma attacks or sudden breathing difficulties. It is designed for long-term management and prevention of symptoms. For quick relief during an asthma attack, a rescue inhaler (short-acting bronchodilator) should be used. Consult your healthcare provider for an appropriate action plan.
What should I do if I miss a dose?
If you miss a dose, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Never double the dose to compensate for a missed one. Maintaining a consistent dosing routine enhances the effectiveness of the treatment.